Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
Rev. saúde pública (Online)
;
54: 94, 2020. tab, graf
Article
in English
| BBO, LILACS
| ID: biblio-1127253
ABSTRACT
ABSTRACT OBJECTIVE:
To perform a cost-benefits analysis of a clinical pharmacy (CP) service implemented in a Neurology ward of a tertiary teaching hospital.METHODS:
This is a cost-benefit analysis of a single arm, prospective cohort study performed at the adult Neurology Unit over 36 months, which has evaluated the results of a CP service from a hospital and Public Health System (PHS) perspective. The interventions were classified into 14 categories and the costs identified as direct medical costs. The results were analyzed by the total and marginal cost, the benefit-cost ratio (BCR) and the net benefit (NB).RESULTS:
The total 334 patients were followed-up and the highest occurrence in 506 interventions was drug introduction (29.0%). The marginal cost for the hospital and avoided cost for PHS was US$182±32 and US$25,536±4,923 per year; and US$0.55 and US$76.4 per patient/year. The BCR and NB were 0.0, -US$26,105 (95%CI −31,850 − -10,610), -US$27,112 (95%CI −33,160-11,720) for the hospital and; 3.0 (95%CI 1.97-4.94), US$51,048 (95%CI 27,645-75,716) and, 4.6 (95%CI 2.24-10.05), US$91,496 (95%CI 34,700-168,050; p < 0.001) for the PHS, both considering adhered and total interventions, respectively.CONCLUSIONS:
The CP service was not directly cost-benefit at the hospital perspective, but it presented savings for forecast cost related to the occurrence of preventable morbidities, measuring a good cost-benefit for the PHS.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Pharmacy Service, Hospital
Type of study:
Health economic evaluation
/
Observational study
Limits:
Adult
/
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Rev. saúde pública (Online)
Journal subject:
Sa£de P£blica
Year:
2020
Type:
Article
Affiliation country:
Brazil
/
Canada
Institution/Affiliation country:
Universidade de Ribeirão Preto/BR
/
Universidade de São Paulo/BR
/
University of Toronto/CA
Similar
MEDLINE
...
LILACS
LIS